Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2010
12/16/2010US20100316991 Human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays
12/16/2010US20100316990 Biomarkers for HPV-Induced Cancer
12/16/2010US20100316989 Method for screening an inhibitory agent of hbv proliferation by using the interaction between hbv capsid and surface proteins based on cellular imaging
12/16/2010US20100316703 Rna interference mediating small rna molecules
12/16/2010US20100316676 Bisphosphonate Compounds and Methods for Bone Resorption Diseases, Cancer, Bone Pain, Immune Disorders, and Infectious Diseases
12/16/2010US20100316653 Compositions and methods for diagnosis and treatment of orthopoxviruses
12/16/2010US20100316643 Targeted antimicrobial moieties
12/16/2010US20100316629 Use of gene expression profiling to predict survival in cancer patient
12/16/2010US20100316626 Methods for treatment and diagnosis of psychiatric disorders
12/16/2010US20100316622 Diagnosis and treatment of cardiac disorders
12/16/2010US20100316617 Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders
12/16/2010US20100316615 Antisense Oligonucleotides Against VR1
12/16/2010US20100316608 Method of Determining A Response To Treatment With Immunomodulatory Composition
12/16/2010US20100316571 Method and Compositions for Polymer Nanocarriers Containing Therapeutic Molecules
12/16/2010US20100316567 Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer stem cells
12/16/2010DE112007002345T5 Primersatz zur Verwendung in der Detektion eines Hefepilzes der Gattung Saccharomyces Primer set for use in the detection of a yeast of the genus Saccharomyces
12/16/2010CA2765314A1 Semiconductor biosensors
12/16/2010CA2764693A1 Risk markers for cardiovascular disease
12/16/2010CA2764638A1 Treatment of coagulopathy with hyperfibrinolysis
12/16/2010CA2764570A1 A method for the transient expression of nucleic acids in plants
12/16/2010CA2764472A1 Aptamer for chymase, and use thereof
12/16/2010CA2763017A1 Combined automated parallel synthesis of polynucleotide variants
12/15/2010EP2261922A2 Playback apparatus and method, recording apparatus and method and recording medium
12/15/2010EP2261669A1 Diagnostic markers of acute coronary syndromes and methods of use thereof
12/15/2010EP2261667A2 Nucleic acid molecules and proteins for the identification, assessment, prevention, and their therapy of ovarian cancer
12/15/2010EP2261665A2 Methods of diagnosing and treating Crohn's disease
12/15/2010EP2261664A2 Methods of treating bloating, abdominal pain and diarrhea
12/15/2010EP2261658A2 IP-10 based infection diagnosis
12/15/2010EP2261657A2 Measurement of substances in liquids
12/15/2010EP2261647A1 Cross-linked enzyme matrix and uses thereof
12/15/2010EP2261380A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins
12/15/2010EP2261379A1 Method and system for detecting and/or quantifying bacteriophages, use of a microelectronic sensor device for detecting said bacteriophages and microelectronic sensor device for implementing said method
12/15/2010EP2261378A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins
12/15/2010EP2261377A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins
12/15/2010EP2261376A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins
12/15/2010EP2261375A2 Method of Preventing Virus:Cell Fusion By Inhibiting the Function of the Fusion Initiation Region in RNA Viruses Having Class I Membrane Fusogenic Envelope Proteins
12/15/2010EP2261374A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class i membrane fusogenic envelope proteins
12/15/2010EP2261373A2 Evolution of whole cells and organisms by recursive sequence recombination
12/15/2010EP2261372A2 Methods of amplifying and sequencing nucleic acids
12/15/2010EP2261371A2 Nucleic acid amplification
12/15/2010EP2261370A1 Method for detecting abnormal spots of nucleic acid microarray
12/15/2010EP2261369A2 Gene expression profiling in biopsied tumor tissues
12/15/2010EP2261368A1 Gene expression profiling in biopsied tumor tissues
12/15/2010EP2261367A2 Gene expression markers for inflammatory bowel disease
12/15/2010EP2261366A1 Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders
12/15/2010EP2261357A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261356A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261355A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261354A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261353A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261352A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261351A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261350A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261349A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261348A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261347A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261346A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261345A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261344A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261343A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261342A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261341A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261340A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261339A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261338A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261335A1 Compositions and methods for increasing bone mineralisation
12/15/2010EP2261332A2 Libraries of recombinant chimeric proteins
12/15/2010EP2261331A1 Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in preventing and/or treating proliferative diseases causing sclerosis
12/15/2010EP2261257A1 Method for making targeted therapeutic agents
12/15/2010EP2261256A2 Methods of inhibiting metastasis
12/15/2010EP2261241A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/15/2010EP2261240A2 Biosensor compositions and methods of use
12/15/2010EP2261228A1 Promoters for regulation of gene expression in plant roots
12/15/2010EP2261227A1 Promoters for regulation of gene expression in plant roots
12/15/2010EP2260942A2 Protease Inhibitor Sample Collection System
12/15/2010EP2260936A2 Method for specifically located synthesis of biopolymers on solid carriers
12/15/2010EP2260842A2 Uses of perfluorinated carboylic acid derivatives for the manufacture of a medicament for the modulation of body mass
12/15/2010EP2260306A1 Use of cathepsin c
12/15/2010EP2260113A2 Process and method for diagnosing alzheimer s disease
12/15/2010EP2260112A2 Method of screening single cells for the production of biologically active agents
12/15/2010EP2260111A2 Genetic variations associated with drug resistance
12/15/2010EP2260110A2 miRNAs DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS
12/15/2010EP2260109A2 Microrna-based methods and compositions for the diagnosis, pronosis and treatment of prostate related disorders
12/15/2010EP2260108A2 Protease assay
12/15/2010EP2260107A2 Assays for diagnosing and evaluating treatment options for pompe disease
12/15/2010EP2260103A2 Direct selection of structurally defined aptamers
12/15/2010EP2260101A1 Microrna (mirna) and downstream targets for diagnostic and therapeutic purposes
12/15/2010EP2066804B1 Method for detection of mutant alleles combining real time pcr and rems-pcr
12/15/2010EP2004852B1 Amplification of dna fragments
12/15/2010EP1877570B1 Analysing breath samples for pentylfuran
12/15/2010EP1831248B1 Pasteurella multocida vaccine
12/15/2010EP1828759B1 Biosensors comprising ruthenium containing mediators and method of using the same
12/15/2010EP1758998B1 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
12/15/2010EP1649043B1 Method for the detection of coliforms and in particular escherichia coli
12/15/2010EP1551999B1 Arrays of electrodes coated with molecules and their production employing masking molecules
12/15/2010EP1525313B1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase
12/15/2010EP1444523B1 Screening for hepatitis c virus entry inhibitors
12/15/2010EP1411954B1 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
12/15/2010EP1112077B1 Method for detection of biological factors in epidermis
12/15/2010EP1076703B2 Therapeutic uses of il-17 homologous polypeptides
1 ... 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 ... 3003